PDL BioPharma, Inc. (
) will begin trading ex-dividend on March 01, 2013. A cash dividend
payment of $0.15 per share is scheduled to be paid on March 12,
2013. Shareholders who purchased PDLI stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
marks the 12th quarter that PDLI has paid the same dividend. At the
current stock price of $7.11, the dividend yield is 8.44%.
The previous trading day's last sale of PDLI was $7.11,
representing a -15.66% decrease from the 52 week high of $8.43 and
a 18.11% increase over the 52 week low of $6.02.
PDLI is a part of the Health Care sector, which includes
companies such as Amgen Inc. (
) and Gilead Sciences, Inc. (
). PDLI's current earnings per share, an indicator of a company's
profitability, is $1.37. Zacks Investment Research reports PDLI's
forecasted earnings growth in 2012 as 23.29%, compared to an
industry average of 10.1%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to PDLI through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:
- WisdomTree Trust SmallCap Dividend Fund (
- WisdomTree SmallCap Earnings Fund (
The top-performing ETF of this group is EES with an increase of
7.31% over the last 100 days. DES has the highest percent weighting
of PDLI at 0.88%.